Neopterin and kynurenine as predictors of depression risk and antiviral efficacy
Neopterin and kynurenine as predictors of depression risk and antiviral efficacy
批准号:
8542902
负责人:
Gregory F Oxenkrug
金额:
$7.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-10 至 2015-07-31
关键词:
AdherenceAdverse effectsAffectAllelesAnabolismAntiviral AgentsAntiviral ResponseBiochemical ReactionBloodBlood specimenChronic Hepatitis CDataEnzymesEvaluationGenesGenetic PolymorphismGenotypeGoalsHealthcareHepatitis C virusIncidenceInfectionInflammationInterferon Type IIInterferon-alphaInterferonsKynurenineLiverLiver CirrhosisMajor Depressive DisorderMental DepressionMetabolismMethodsMultiple SclerosisNeopterinOutcomeParticipantPatientsPegylated Interferon AlfaPlasmaPopulationPrimary carcinoma of the liver cellsProductionProtease InhibitorPteridinesReportingRibavirinRiskRoleSerumTestingTryptophanVirusWorkanti-viral efficacybasecost effectivegenome wide association studyhigh riskinflammatory markerliver transplantationmelanomanovel markerpremature
中文摘要
描述(由申请人提供):干扰素(IFN)-α治疗丙型肝炎病毒(HCV)的疗效有限,并涉及频繁和严重的精神副作用。预测抑郁症的风险和IFN-α治疗的抗病毒疗效对于患者的健康和医疗费用都非常重要。IFN-刺激的基因(IFN-SG)同时上调形成新蝶呤(蝶啶生物合成的副产物)和犬尿氨酸(KYN)(色氨酸(TRY)代谢物)的限速酶。我们发现抗病毒应答差的患者(HCV基因型2和3)血浆新蝶呤水平升高; IFN-α诱导的抑郁症与编码IFN-γ产生的IFN-γ基因的高产等位基因相关,IFN-γ是TRY-KYN代谢的最强诱导剂。[1]我们认为,KYN/TRY比值升高预示抑郁症的高风险,新蝶呤水平低预示IFN-α治疗的阳性抗病毒反应。为了验证这一假设,我们建议评估新蝶呤,KYN和TRY水平在已经收集的血液样本的300 HCV参与者从我们完成的研究IFNG(+874)T/A基因多态性在IFN-α诱导的抑郁症。我们的研究将有助于开发快速和具有成本效益的方法,预测IFN-α治疗(单独和与利巴韦林或蛋白酶抑制剂联合)HCV(和其他可用IFN-α治疗的疾病,例如,黑色素瘤、多发性硬化症);并帮助理解炎症在重度抑郁症中的作用。
英文摘要
DESCRIPTION (provided by applicant): Interferon (IFN)-alpha treatment of hepatitis C virus (HCV) has limited efficacy and involves frequent and severe psychiatric side-effects. Prediction of risk for depression and antiviral efficacy of IFN-alpha treatment is of great importance for bot patient wellbeing and health care expense. IFN- stimulated genes (IFN-SGs) concurrently up-regulates rate-limiting enzymes of formation of neopterin, a by-product of pteridines biosynthesis, and kynurenine (KYN), a tryptophan (TRY) metabolite. We found elevated plasma levels of neopterin in patients (HCV genotypes 2 and 3) with poor anti-viral response; and association of IFN-alpha-induced depression with a high producer allele of IFN-gamma gene that encodes production of IFN-gamma, the strongest inducer of TRY - KYN metabolism.[1] We suggest that elevated KYN/TRY ratio predicts high risk of depression and low neopterin levels predict positive anti-viral response to IFN-alpha treatment. To test this hypothesis we propose to assess neopterin, KYN and TRY levels in already collected blood samples of 300 HCV participants from our completed study of IFNG (+874) T/A gene polymorphisms in IFN-alpha-induced depression. Our study will help to develop rapid and cost-effective methods predicting the major outcomes of IFN-alpha therapy (alone and in combination with ribavirin or protease inhibitors) of HCV (and other conditions treatable with IFN-alpha, e.g., melanoma, multiple sclerosis); and help to understand the role of inflammation in major depressive disorder.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Depression, insulin resistance and xanthurenic acid in hepatitis C virus patients
-
批准号:8772121
-
项目类别:
-
资助金额:$8.76万
-
财政年份:2014
-
负责人:Gregory F Oxenkrug
-
依托单位:
Neopterin and kynurenine as predictors of depression risk and antiviral efficacy
-
批准号:8430663
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2012
-
负责人:Gregory F Oxenkrug
-
依托单位:
Genetic Regulation of Indoleamine-2,3-dioxygenase and Psychiatric Complications o
-
批准号:7799933
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2009
-
负责人:Gregory F Oxenkrug
-
依托单位:
Genetic Regulation of Indoleamine-2,3-dioxygenase and Psychiatric Complications o
-
批准号:7660194
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2009
-
负责人:Gregory F Oxenkrug
-
依托单位:
海外基金